PREP lab got a 2-year Business Finland TUTLI funding at the beginning of 2019, and the aim of this funding is to improve commercialization of research results. Our project aims to find a commercialization route for our novel PREP inhibitors to combat neurodegenerative diseases. Now, our TUTLI team has grown with a commercial champion Samuli, that will further strenghten our activities in this field. Samuli is very well known person in pharmacy field in Finland, as he has been actively participating on different pharmacy organizations, including student's associations and Proviisoriyhdistys. Importantly, Samuli made part of his M.Sc. studies in 3i-regeneration project, and got experience on drug discovery and development. Welcome Samuli!